Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Douglas LESLIE |
Documents disponibles écrits par cet auteur (2)
Faire une suggestion Affiner la recherche
Changes in healthcare expenditures after the autism insurance mandate / Li WANG in Research in Autism Spectrum Disorders, 57 (January 2019)
[article]
Titre : Changes in healthcare expenditures after the autism insurance mandate Type de document : Texte imprimé et/ou numérique Auteurs : Li WANG, Auteur ; Junyi MA, Auteur ; Ruchita DHOLAKIA, Auteur ; Callie HOWELLS, Auteur ; Yun LU, Auteur ; Chen CHEN, Auteur ; Runze LI, Auteur ; Michael MURRAY, Auteur ; Douglas LESLIE, Auteur Article en page(s) : p.97-104 Langues : Anglais (eng) Mots-clés : Autism mandate Healthcare expenditures Cost Autism spectrum disorder Private insurance Index. décimale : PER Périodiques Résumé : Background In recent years, most U.S. states have passed autism mandates requiring private insurers to cover autism spectrum disorders (ASD). Little is known about the post-mandate changes in healthcare expenditures. Method This study utilized 2006–2012 de-identified insurance claims data from the largest private insurer in Pennsylvania (PA), where the mandate went into effect in mid 2009. Healthcare expenditures were defined as the amount the insurer paid for healthcare services and were adjusted to 2012 price level. A mixed effects model was used to analyze the expenditures. Results A total of 9471 children with ASD were included. Although the pre-mandate total expenditures per child with ASD were similar, the post-mandate expenditures significantly increased for groups subject to the autism mandate (87% increase from $7754 in 2008 to $14,486 in 2010) compared to the exempt groups (27% increase from $7238 to $9171). By insurance type, the change from 2008 to 2010 in ASD-related expenditures per child with ASD was $8439 for fully insured large employer sponsored plans and $43 for the Children’s Health Insurance Program (CHIP), both subject to the PA mandate; and $2631 for the self-insured, $980 for small-employers, and $-92 for individual plans, all of which are exempt from the mandate. These increases were due to outpatient services but not inpatient or drug costs. Conclusions Healthcare expenditures increased significantly following the PA autism mandate. Nonexempt, large employer groups had the largest increase in spending. Some exempt, self-insured companies may have voluntarily covered ASD services, leading to a moderate increase. En ligne : https://doi.org/10.1016/j.rasd.2018.10.004 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=371
in Research in Autism Spectrum Disorders > 57 (January 2019) . - p.97-104[article] Changes in healthcare expenditures after the autism insurance mandate [Texte imprimé et/ou numérique] / Li WANG, Auteur ; Junyi MA, Auteur ; Ruchita DHOLAKIA, Auteur ; Callie HOWELLS, Auteur ; Yun LU, Auteur ; Chen CHEN, Auteur ; Runze LI, Auteur ; Michael MURRAY, Auteur ; Douglas LESLIE, Auteur . - p.97-104.
Langues : Anglais (eng)
in Research in Autism Spectrum Disorders > 57 (January 2019) . - p.97-104
Mots-clés : Autism mandate Healthcare expenditures Cost Autism spectrum disorder Private insurance Index. décimale : PER Périodiques Résumé : Background In recent years, most U.S. states have passed autism mandates requiring private insurers to cover autism spectrum disorders (ASD). Little is known about the post-mandate changes in healthcare expenditures. Method This study utilized 2006–2012 de-identified insurance claims data from the largest private insurer in Pennsylvania (PA), where the mandate went into effect in mid 2009. Healthcare expenditures were defined as the amount the insurer paid for healthcare services and were adjusted to 2012 price level. A mixed effects model was used to analyze the expenditures. Results A total of 9471 children with ASD were included. Although the pre-mandate total expenditures per child with ASD were similar, the post-mandate expenditures significantly increased for groups subject to the autism mandate (87% increase from $7754 in 2008 to $14,486 in 2010) compared to the exempt groups (27% increase from $7238 to $9171). By insurance type, the change from 2008 to 2010 in ASD-related expenditures per child with ASD was $8439 for fully insured large employer sponsored plans and $43 for the Children’s Health Insurance Program (CHIP), both subject to the PA mandate; and $2631 for the self-insured, $980 for small-employers, and $-92 for individual plans, all of which are exempt from the mandate. These increases were due to outpatient services but not inpatient or drug costs. Conclusions Healthcare expenditures increased significantly following the PA autism mandate. Nonexempt, large employer groups had the largest increase in spending. Some exempt, self-insured companies may have voluntarily covered ASD services, leading to a moderate increase. En ligne : https://doi.org/10.1016/j.rasd.2018.10.004 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=371 Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program / Jane R. SCHUBART in Autism, 18-6 (August 2014)
[article]
Titre : Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program Type de document : Texte imprimé et/ou numérique Auteurs : Jane R. SCHUBART, Auteur ; Fabian CAMACHO, Auteur ; Douglas LESLIE, Auteur Article en page(s) : p.631-637 Langues : Anglais (eng) Mots-clés : autism spectrum disorder children and adolescents Medicaid psychotropic medications Index. décimale : PER Périodiques Résumé : This study characterized psychotropic medication use among Medicaid-enrolled children and adolescents with autism spectrum disorders by examining trends over time, including length of treatment and polypharmacy using 4 years of administrative claims data from 41 state Medicaid programs (2000–2003). The data set included nearly 3 million children and adolescents who were 17 years or younger. Approximately, 65% of children with autism spectrum disorder received a psychotropic medication. The results indicate an increasing overall trend in the use of psychotropic drugs among children and adolescents with autism spectrum disorders. Among the different classes of psychotropic drugs, antipsychotics were the most common. Increasing trends in polypharmacy were observed both within and between medication classes. En ligne : http://dx.doi.org/10.1177/1362361313497537 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=237
in Autism > 18-6 (August 2014) . - p.631-637[article] Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program [Texte imprimé et/ou numérique] / Jane R. SCHUBART, Auteur ; Fabian CAMACHO, Auteur ; Douglas LESLIE, Auteur . - p.631-637.
Langues : Anglais (eng)
in Autism > 18-6 (August 2014) . - p.631-637
Mots-clés : autism spectrum disorder children and adolescents Medicaid psychotropic medications Index. décimale : PER Périodiques Résumé : This study characterized psychotropic medication use among Medicaid-enrolled children and adolescents with autism spectrum disorders by examining trends over time, including length of treatment and polypharmacy using 4 years of administrative claims data from 41 state Medicaid programs (2000–2003). The data set included nearly 3 million children and adolescents who were 17 years or younger. Approximately, 65% of children with autism spectrum disorder received a psychotropic medication. The results indicate an increasing overall trend in the use of psychotropic drugs among children and adolescents with autism spectrum disorders. Among the different classes of psychotropic drugs, antipsychotics were the most common. Increasing trends in polypharmacy were observed both within and between medication classes. En ligne : http://dx.doi.org/10.1177/1362361313497537 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=237